D
ORIC Pharmaceuticals, Inc. ORIC
$4.59 -$0.29-5.94%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -28.16% -35.67% -39.31% -4.45% -35.89%
Total Depreciation and Amortization 15.59% 5.06% 5.02% 3.16% 6.48%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 96.86% 60.14% 5.02% -0.80% -28.90%
Change in Net Operating Assets 120.77% -34.26% 426.48% -2,726.05% -27.09%
Cash from Operations -15.59% -46.59% -21.19% -46.34% -58.33%
Capital Expenditure -284.21% -442.86% 17.78% 29.68% 80.14%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 103.97% 140.67% 198.44% -571.04% -26.47%
Cash from Investing 103.48% 139.89% 194.65% -584.18% -25.93%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 26.65% 306.45% -99.04% -- -98.20%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 100.00% -- 100.00% -- 99.75%
Cash from Financing 26.93% 306.45% -99.04% -- -98.17%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 631.74% 92.77% -114.60% 520.08% -107.56%
Weiss Ratings